Title : Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).

Pub. Date : 2021 Jan

PMID : 33479025






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We hypothesized that adding toll-like receptor 3 agonist polyICLC to an incomplete Freund"s adjuvant (IFA) would be safe and would support strong, durable CD4+ T cell and Ab responses. poly ICLC toll like receptor 3 Homo sapiens